About AllianceBernstein L.P.
AllianceBernstein L.P. is a leading global investment management firm providing investment management services for many of the largest U.S. public and private employee benefit plans, foundations, public employee retirement funds, pension funds, endowments, banks, insurance companies, and high-net-worth individuals worldwide. AllianceBernstein is also one of the largest mutual fund sponsors, with a diverse family of globally distributed mutual fund portfolios. Through its subsidiary, Sanford C. Bernstein & Co., LLC, AllianceBernstein provides in-depth research, portfolio strategy, and trade execution to the institutional investment community. www.alliancebernstein.com
Alta Partners
Alta Partners is a San Francisco-based venture capital firm focused on life sciences investing. Founded in 1996, the firm has raised over $2 billion in capital through eight venture fund programs. Alta invests in life sciences companies across the development continuum, from company formation to later-stage opportunities, and has funded more than 130 companies in the sector to date. www.altapartners.com
About BioAdvance
As part of a $2 billion initiative of the Commonwealth of Pennsylvania for the life sciences, BioAdvance received $33.8 million to accelerate the creation of life-sciences jobs and businesses in Southeastern Pennsylvania. Since its inception in 2002, BioAdvance has committed more than $10 million of its Greenhouse Fund to 29 enterprises and research projects. Their technologies and products cover an array of innovations - from powerful new diagnostics to medical devices and promising therapies for a variety of disabling and life threatening conditions including cancer, Alzheimer's disease, macular degeneration, obesity, drug resistant infections, intractable pain, and
addiction. For more information on BioAdvance and its portfolio companies, visit www.bioadvance.com.
About Lilly Ventures
Lilly Ventures is the venture capital arm of Eli Lilly and Company, a leading innovation-driven pharmaceutical company. Their primary goal is to facilitate the success of companies in their areas of focus through early to expansion stage investments and value-adding resources. Lilly Ventures currently has $175 million under management and focuses on three major areas of interest: biotechnology, healthcare IT, and medical technology.
About Pfizer Strategic Investments Group
Pfizer Strategic Investments Group (PSIG) is part of Pfizer Inc., which discovers, develops, and markets leading prescription medicines for humans and animals and many of the world's best known consumer brands. PSIG invests in companies that develop or market technologies, products or services that could advance Pfizer's interests. For more information, visit www.pfizer.com/psig/.
About RK Ventures
RK Ventures is a venture capital partnership that provides capital and management support to seed and early-stage companies in financial services, software, and biotechnology. RK Ventures identifies entrepreneurs who are passionate about their vision and who have the skills and background to make that vision a reality. RK Ventures is directed by Matthew Rhodes-Kropf a professor at Harvard Business School.
About Safeguard Scientifics, Inc.
Founded in 1953 and based in Wayne, PA, Safeguard Scientifics, Inc. (NYSE: SFE) provides growth capital for entrepreneurial and innovative life sciences and technology companies. Safeguard targets life sciences companies in Molecular and Point-of-Care Diagnostics, Medical Devices, Regenerative Medicine and Specialty Pharmaceuticals, and technology companies in Internet / New Media, Financial Services IT and Healthcare IT with capital requirements of up to $25 million. Safeguard participates in expansion financings, corporate spin-outs, management buyouts, recapitalizations, industry consolidations, and early-stage financings. www.safeguard.com